Brelovitug 900 mg

Drug identity checked against registry records

Also recorded as BJT-778; BTG

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)NCT07298330MIRMPhase 3Active not recruiting2026-08Estimated
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionNCT06907290MIRMPhase 2, Phase 3Active not recruiting2029-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.